CIOTTA, Liliana
 Distribuzione geografica
Continente #
NA - Nord America 4.125
EU - Europa 1.831
AS - Asia 1.817
SA - Sud America 281
AF - Africa 276
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 8.338
Nazione #
US - Stati Uniti d'America 3.970
SG - Singapore 895
RU - Federazione Russa 615
CN - Cina 580
IE - Irlanda 310
UA - Ucraina 308
BR - Brasile 242
IT - Italia 223
CA - Canada 127
VN - Vietnam 124
CI - Costa d'Avorio 109
FR - Francia 105
SN - Senegal 90
DE - Germania 67
SE - Svezia 63
KR - Corea 48
NG - Nigeria 45
IN - India 35
GB - Regno Unito 34
BD - Bangladesh 21
CH - Svizzera 19
MX - Messico 19
PL - Polonia 17
AR - Argentina 16
UZ - Uzbekistan 16
NL - Olanda 15
ZA - Sudafrica 14
HK - Hong Kong 13
AT - Austria 12
JP - Giappone 12
IQ - Iraq 11
TR - Turchia 11
ES - Italia 9
FI - Finlandia 8
EC - Ecuador 7
ID - Indonesia 7
PK - Pakistan 7
AE - Emirati Arabi Uniti 6
JO - Giordania 6
CO - Colombia 5
MY - Malesia 5
DZ - Algeria 4
EU - Europa 4
GR - Grecia 4
LB - Libano 4
SA - Arabia Saudita 4
TN - Tunisia 4
VE - Venezuela 4
BE - Belgio 3
EG - Egitto 3
KE - Kenya 3
RO - Romania 3
RS - Serbia 3
AL - Albania 2
AO - Angola 2
AU - Australia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
GE - Georgia 2
HU - Ungheria 2
JM - Giamaica 2
LT - Lituania 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
PY - Paraguay 2
SI - Slovenia 2
UY - Uruguay 2
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
GY - Guiana 1
IL - Israele 1
IR - Iran 1
KZ - Kazakistan 1
MA - Marocco 1
MD - Moldavia 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
PW - Palau 1
TJ - Tagikistan 1
TV - Tuvalu 1
VC - Saint Vincent e Grenadine 1
Totale 8.338
Città #
Santa Clara 662
Dallas 544
Singapore 514
Ashburn 390
Jacksonville 345
Dublin 307
Chandler 298
Moscow 254
San Jose 246
Chicago 155
Boardman 141
Beijing 110
Abidjan 109
Nanjing 91
Dakar 90
Cambridge 88
Lawrence 87
Toronto 87
Andover 83
Lauterbourg 78
Los Angeles 75
San Mateo 50
Civitanova Marche 48
Hefei 48
Nanchang 43
Des Moines 41
Wilmington 40
Ho Chi Minh City 34
Bremen 32
Hanoi 31
Seoul 29
Hebei 28
New York 28
Tianjin 27
Changsha 26
Saint Petersburg 24
São Paulo 24
Buffalo 23
Shenyang 23
Orem 22
Abuja 21
Jiaxing 20
Ottawa 20
Seongnam 17
Council Bluffs 16
Lagos 15
Taormina 15
Warsaw 14
Hong Kong 13
Munich 12
Rome 12
Tokyo 12
Brooklyn 11
Montreal 10
Seattle 10
Catania 9
Port Harcourt 9
Tashkent 9
Milan 8
Phoenix 8
San Francisco 8
Amsterdam 7
Chennai 7
Denver 7
Helsinki 7
Jinan 7
The Dalles 7
Ankara 6
Belo Horizonte 6
Brasília 6
Columbus 6
Naples 6
Ningbo 6
Pune 6
Zhengzhou 6
Amman 5
Atlanta 5
Baghdad 5
Boston 5
Campinas 5
Charlotte 5
Da Nang 5
Den Haag 5
Haiphong 5
Hangzhou 5
Mexico City 5
Norwalk 5
Poplar 5
Porto Alegre 5
Rio de Janeiro 5
Stockholm 5
Ann Arbor 4
Can Tho 4
Curitiba 4
Dhaka 4
Dong Ket 4
Durban 4
Frankfurt Am Main 4
Guarulhos 4
Isernia 4
Totale 5.850
Nome #
Intracesarean removal of two huge fibroids occupying the whole uterine fundus: A case report 340
A specific application of locus of control of behaviour scale on patients with pelvic floor alteration 182
Acetyl-L-Carnitine in the treatment of patients with weight-loss related to hypothalamic amenorrhea 156
Effects of Myo-Inositol supplementation on oocyte’s quality in PCOS patients: a double blind trial 149
D-Chiro-Inositol treatment in patients with polycystic ovary syndrome 149
Adolescents and PCOS: Last update on diagnosis and therapy 143
Hydronephrosis and utero-vaginal prolapse in postmenopausal women: management and treatment 142
Protection of ovarian tissue from radiotherapy 139
ASPETTI PSICHICI DELLA SINDROME PREMESTRUALE (PMS) E DISTURBO DISFORICO DELLA FASE LUTEALE (PMDD): NUOVE PROSPETTIVE TERAPEUTICHE, IL VITEX AGNUS CASTUS (VAC) : NOSTRE ESPERIENZE 137
Clinical efficacy of n-oleyl-phosphatidyl-ethanolamine (NOPE) in obesity: Our experience [Efficacia clinica della n-oleil-fosfatidil-etanolamina (NOPE) nella terapia dell'obesità: Nostra esperienza] 134
Contraccezione orale con estro-progestinici e sviluppo di mastopatie benigne 133
Clinical and endocrine effects of finasteride, a 5a-reductase inhibitor, in women with idiopathic hirsutism 132
Clinical, endocrine and metabolic effects of acarbose, an alpha-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance 131
Adrenal steroid secretion in postmenopausal women during raloxifene therapy 130
B19 Parvovirus non-immune hydrops fetalis: a case report. 129
Diabetes in pregnancy: Focus on complications [Diabete in Gravidanza: Focus sulle Complicanze] 127
Clinical affects of finasteride , 5-a-reductase inhibitor in post menopausal women with hair loss 126
Correlation between thyroid function and post-partum depression: preliminary dates on sample study 120
Effects of inositol on oocytes’ quality in patients with polycystic ovary syndrome 119
Clinical and hormonal effects of gonadotropin-releasing hormone agonist plus an oral contraceptive in severely hirsute patients with polycystic ovary disease 116
The reproduction in women affected by cooley disease 115
Clomiphene citrate and dydrogesterone: a combined therapy for functional hypothalamic amenorrhea 114
Aspetti metabolici ed epatici della policistosi ovarica 112
Laparoscopic removal of a giant paratubal cyst complicated by hydronephrosis 111
Terapia ormonale sostitutiva: effetti sull’endometrio in donne a rischio di adenocarcinoma endometriale 110
L-thyroxin treatment and post-menopausal osteoporosis: relevance of the risk profile present in clinical history 107
Effects of genisteina and daidzeina in climateric symptoms and postmenopausal bone loss 107
Clomiphene citrate increases insulin-like growth factor binding protein-1 and reduces insulin-like growth factor-I without correcting insulin resistance associated with polycystic ovarian syndrome 107
PCOS treatment with an oral contraceptive containing Drospirenone, alone or in association with D-Chiro-Inositol 105
Male equivalent polycystic ovarian syndrome: Hormonal, metabolic and clinical aspects 102
Studio prospettivo sulla riparazione del cistocele con allografts in derma porcino tipo Pelvisoft (Bard Urological) 96
Screening for preeclampsia by uterine artery Doppler velocimetry in the late first trimester of pregnancy 95
Myo-inositol vs D-Chiro-Inositol in PCOS treatment 93
Effetti del trattamento con metaformina sulla distribuzione corporea dell'adipe, sul profilo lipidico e sulla risposta insulinemica in donne affette da sindrome dell'ovaio policistico 93
Iter diagnostico e terapeutico delle amenorre 92
A case report of asymptomatic placenta previa: diagnosis and management 92
Terapia del diabete gestazionale: gli attuali approcci 89
Effects of myo-inositol, gymnemic acid, and L-methylfolate in polycystic ovary syndrome patients 87
Endocrine and metabolic effects of insulin sensitizers in the treatment of patients with polycystic ovary syndrome and hyperinsulinaemia 86
The efficacy of a pollen extract as non estrogenic alternative to hormone replacement therapy in symptomatic perimenopausal women 84
Uterine bleeding pattern during low dosage Noretisterone acetate and 17-b-Estradiol treatment in postmenopausal patients 84
Evaluation of plasma levels of renin-aldosterone and blood pressure in women over 35 years treated with new oral contraceptives 83
Tolleranza clinica e metabolica del trattamento long-term con alendronato (70 mg) 82
Influence of sport and low animal saturated fats intake diet on lipid dismetabolisms in postmenopausal women 81
Efficacia dell’a-tocoferolo acetato (100% vitamina E) per via vaginale nella prevenzione delle erosioni dopo riparazione protesica del prolasso urogenitale 81
Medical therapy for endometriosis: a literature review. 81
Oral contraception and benign breast disease 79
Original study: role of BMP-15 in the pathogenesis of premature ovarian failure (POF) 79
Efficacia e sicurezza del nuovo contraccettivo orale antiandrogeno contenente Clormadinone Acetato (Belaro) follow up a 12 mesi 79
Efficacy of Cimicifuga Racemosa on Menopausal Symptoms in Women with Breast Cancer 77
Trattamento topico dell’irsutismo facciale con eflornitina in donne in post-menopausa 77
Effetti sul metabolismo lipidico e sui parametri emocoagulativi della terapia con raloxifene in donne osteoporotiche in postmenopausa 77
Effetti della terapia con metformina in pazienti obese con PCOS 76
Effetti della genisteina e daidzeina sui sintomi climaterici e sulla perdita ossea in donne in postmenopausa 75
Procreazione Medicalmente Assistita ed Endometriosi 74
Oral Contraception and Breast Diseases. 73
Risultati clinici e metabolici durante il trattamento con Alendronato con somministrazione settimanale 73
Influence of HRT on body mass index, arterial pressure profile and lipidic metabolism in postmenopausal women 73
Problematiche terapeutiche in donne affette da POF (premature ovarian faiilure) 73
Weight change and adverse event incidence with a different combined estradiol-progestin regimens in postmenopausal women 72
Fisiologia delle amenoree 72
Innovative genetic, clinical and endocrinological aspects in young females affected with premature ovarian insufficiency [Innovativi aspetti genetici, clinici ed endocrini in una giovane popolazione femminile affetta da insufficienza ovarica prematura] 72
Pseudoachantosis nigricans: a skin maker for hyperinulinemia 71
Metabolismo osseo in donne in postmenopausa in trattamento con fitoestrogeni 71
Evaluation of thyroid function at delivery and in the first 6 months postpartum: preliminary data in a Sicilian Sample study 71
Polycystic ovarian syndrome incidence in young women with non-alcoholic fatty liver disease 71
Trattamento "long-term" con dosi ridotte di flutamide nella prevenzione della recidive sitomatologiche in pazieti con PCOS 70
Incidenza di eventi avversi durante terapia con dose monosettimanale (70 mg) o giornaliera (10 mg) di alendronato in donne osteopeniche in postmenopausa 70
Relationship between serum anti-Mullerian hormone and intrafollicular AMH levels in PCOS women 70
Monoprotesi per il trattamento simultaneo del cistocele e dell’incontinenza urinaria da stress (protocollo NAZCA): studio prospettico 69
Low birth-weight is a PCOS risk factor for Southern-Italian women 68
ISOLATED ELEVATED LIVER ENZYME AT 28°WEEK OF GESTATION: A CASE REPORT 68
Subclinical hypothyroidism among subjective and objective symptoms in menopause transition: prevalence and incidence 68
Profili lipidici ed emocoagulativi in donne in postmenopausa in trattamento con raloxifene 68
Trattamento con Gn-RH analogo per la protezione del potenziale riproduttivo in giovani donne affette da linfoma di Hodking e non Hodking 68
Effetti del Myo-inositolo sulla qualità ovocitaria in pazienti affette da Sindrome dell’Ovaio Policistico 68
Hydronephrosis due to voluminous adnexial mass in a teenager: management and treatment 67
Induction of ovulation in thalassemic patients 65
Relationship between tumour necrosis factor alpha and sex steroid concentrations in the follicular fluid of women with immunological infertility 65
Role of DEXA and ultrasonometry in the evaluation of osteoporotic risk in postmenopausal women 65
Patologia mammaria benigna e gravidanza 65
Therapetic strategies in women affected by premature ovarian failure 62
Effetti della genisteina sulla perdita ossea in donne in post menopausa 62
Metabolic Aspects of PCOS Treatment with Insulin Sensitizers 59
Profili lipidici ed emocoagulativi in donne in postmenopausa in trattamento con raloxifene 2008 57
Genetics pathogenesis in the ovarian insufficiency 56
Il carcinoma mammario e gravidanza 55
Problematiche terapeutiche in donne affette da POF (premature ovarian failure) 55
Fertility after multiple myomectomy 54
Long-term treatement with low-dose flutamide in the syntomatic relapses prevention of patient suffering from PCOS 51
Totale 8.433
Categoria #
all - tutte 27.521
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.521


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202130 0 0 0 0 0 0 0 0 0 0 0 30
2021/2022623 85 91 4 10 96 1 84 22 69 0 27 134
2022/2023995 90 55 12 103 82 169 2 205 243 7 19 8
2023/2024557 19 59 9 33 18 58 1 246 0 5 64 45
2024/20251.746 13 285 92 59 487 277 6 43 108 146 89 141
2025/20263.211 234 140 625 162 563 634 387 50 146 127 98 45
Totale 8.433